Business · 16/04/2004
FDA Announces Approval of Postmarketing Study Collection for Human Drugs and Biological Products
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to postmarketing studies for human drugs and licensed biological products, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →